December 18, 2020

Antifungal drug improves key cystic fibrosis biomarkers in clinical study

  • By Liz Ahlberg Touchstone

CHAMPAIGN, Ill. — A drug widely used to treat fungal infections improved key biomarkers in lung tissue cultures as well as in the noses of patients with cystic fibrosis, a clinical study by researchers at the University of Illinois Urbana-Champaign and the University of Iowa found. Cystic fibrosis is caused by a missing or defective ion channel in the lining of the lungs, called CFTR. This leaves patients vulnerable to lung infections. Treatments called modulators […]